NASDAQ:APM - Aptorum Group Stock Price, News, & Analysis

+1.38 (+6.16 %)
(As of 06/17/2019 04:00 PM ET)
Today's Range
Now: $23.80
50-Day Range
MA: $24.66
52-Week Range
Now: $23.80
Volume3,600 shs
Average Volume5,854 shs
Market Capitalization$688.46 million
P/E RatioN/A
Dividend YieldN/A
Aptorum Group Limited, a pharmaceutical company, develops and commercializes a range of therapeutic and diagnostic technologies to treat unmet medical needs. It focuses on developing various drug molecules and certain technologies for the treatment and diagnosis of human disease conditions in neurology, infectious diseases, gastroenterology, oncology, and other disease areas. The company also focuses on the development of surgical robotics and medical devices; and operating outpatient clinic. Aptorum Group Limited was incorporated in 2010 and is headquartered in Central, Hong Kong.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Current SymbolNASDAQ:APM



Sales & Book Value

Annual Sales$380,000.00
Book Value$1.13 per share



Market Cap$688.46 million
Next Earnings Date7/15/2019 (Estimated)
OptionableNot Optionable

Receive APM News and Ratings via Email

Sign-up to receive the latest news and ratings for APM and its competitors with MarketBeat's FREE daily newsletter.

Aptorum Group (NASDAQ:APM) Frequently Asked Questions

What is Aptorum Group's stock symbol?

Aptorum Group trades on the NASDAQ under the ticker symbol "APM."

When is Aptorum Group's next earnings date?

Aptorum Group is scheduled to release their next quarterly earnings announcement on Monday, July 15th 2019. View Earnings Estimates for Aptorum Group.

What price target have analysts set for APM?

1 Wall Street analysts have issued twelve-month target prices for Aptorum Group's stock. Their forecasts range from $22.00 to $22.00. On average, they anticipate Aptorum Group's stock price to reach $22.00 in the next twelve months. This suggests that the stock has a possible downside of 7.6%. View Analyst Price Targets for Aptorum Group.

What is the consensus analysts' recommendation for Aptorum Group?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aptorum Group in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Aptorum Group.

Has Aptorum Group been receiving favorable news coverage?

Headlines about APM stock have trended somewhat positive recently, according to InfoTrie Sentiment. The research group identifies negative and positive media coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Aptorum Group earned a coverage optimism score of 1.4 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an effect on the company's share price in the near future. View News Stories for Aptorum Group.

Are investors shorting Aptorum Group?

Aptorum Group saw a increase in short interest in the month of May. As of May 15th, there was short interest totalling 16,400 shares, an increase of 127.8% from the April 15th total of 7,200 shares. Based on an average daily trading volume, of 6,500 shares, the short-interest ratio is presently 2.5 days. Currently, 0.4% of the shares of the stock are sold short. View Aptorum Group's Current Options Chain.

Who are some of Aptorum Group's key competitors?

What other stocks do shareholders of Aptorum Group own?

Who are Aptorum Group's key executives?

Aptorum Group's management team includes the folowing people:
  • Mr. Chung Yuen Huen, Founder, CEO & Exec. Director (Age 39)
  • Mr. Darren Lui, Pres, Chief Bus. Officer & Exec. Director (Age 38)
  • Ms. Sabrina Khan, Chief Financial Officer (Age 37)
  • Dr. Siu-yan Ng, Chief Operating Officer (Age 38)
  • Mr. Clark Cheng, Chief Medical Officer & Exec. Director (Age 39)

When did Aptorum Group's lock-up period expire?

Aptorum Group's lock-up period expired on Monday, June 17th. Aptorum Group had issued 1,898,734 shares in its public offering on December 18th. The total size of the offering was $29,999,997 based on an initial share price of $15.80. Shares of the company owned by company insiders and major shareholders are now eligible to be traded as a result of the expiration of the lock-up period.

How do I buy shares of Aptorum Group?

Shares of APM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Aptorum Group's stock price today?

One share of APM stock can currently be purchased for approximately $23.80.

How big of a company is Aptorum Group?

Aptorum Group has a market capitalization of $688.46 million and generates $380,000.00 in revenue each year. Aptorum Group employs 39 workers across the globe.View Additional Information About Aptorum Group.

What is Aptorum Group's official website?

The official website for Aptorum Group is

How can I contact Aptorum Group?

Aptorum Group's mailing address is 17/F GUANGDONG INVESTMENT TOWER 148 CONNAUGHT ROAD CENTRAL, Hong Kong K3, 999077. The company can be reached via phone at 852-2117-6611 or via email at [email protected]

MarketBeat Community Rating for Aptorum Group (NASDAQ APM)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  8 (Vote Outperform)
Underperform Votes:  10 (Vote Underperform)
Total Votes:  18
MarketBeat's community ratings are surveys of what our community members think about Aptorum Group and other stocks. Vote "Outperform" if you believe APM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe APM will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/17/2019 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel